OpenScience.ink

1 week ago • Current issues in molecular biology

Different Anti-Inflammatory Effects of Semaglutide and Tirzepatide in DiabetesDifferential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus.

📖 Top 30% JournalArticle

1 week ago • Frontiers in endocrinology

Gut bacteria may influence how people respond to GLP-1 receptor drugsThe gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review.

🎖️ Top 10% JournalArticle

1 week ago • Journal of clinical medicine

Mouth Health Effects of GLP-1 Receptor Agonists and Similar Diabetes TreatmentsOral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies.

📖 Top 20% JournalArticle

1 week ago • Nutrients

Plant-Based Compounds as Additional Treatments for Obesity Beyond GLP-1 DrugsBeyond GLP-1 Agonists: Plant-Derived Bioactive Compounds as Adjunctive Strategies for Obesity Management.

🎖️ Top 10% JournalArticle

1 week ago • Pharmaceutics

Making Oral Tirzepatide Tablets Using Sodium Caprate to Improve Peptide Absorption in the StomachOvercoming Gastric Barriers for Oral Peptide Delivery: QbD-Based Development of Sodium Caprate-Enabled Tirzepatide Tablets.

📖 Top 20% JournalArticle

1 week ago • European heart journal open

Glucagon-like peptide-1 receptor agonists linked to heart, cancer, and survival benefits in diabetic patients treated with anthracyclinesGlucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclines.

🎖️ Top 10% JournalArticle

1 week ago • International journal of molecular sciences

How Incretin-Based Drugs May Boost Sports Performance and Their Implications for DopingIncretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review.

📖 Top 20% JournalArticle

1 week ago • Journal of the Society for Cardiovascular Angiography & Interventions

Tirzepatide use and health outcomes after heart valve replacement in obese patientsAssociation of Tirzepatide Use With Clinical Outcomes After TAVR in Obese Patients: A Propensity Score-Matched Real-World Study.

📖 Top 30% JournalArticle

1 week ago • Frontiers in endocrinology

Tirzepatide and fatty liver disease linked to metabolism in people with obesity: a real-world multicenter studyTirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study.

🎖️ Top 10% JournalMulticenter Study

1 week ago • Biomedicines

Tirzepatide reduces artery changes after injury in mice with and without diabetes, compared to semaglutideTirzepatide Attenuates Wire Injury-Induced Arterial Remodeling in Non-Diabetic and Diabetic Mice: Comparison with Semaglutide.

📖 Top 20% JournalArticle

1 week ago • Journal of the Society for Cardiovascular Angiography & Interventions

Link Between GLP-1 Receptor Agonist Treatment Around Carotid Artery Stenting and Major Heart and Stroke Problems Within One YearAssociation of Periprocedural GLP-1 Receptor Agonist Therapy With 1-Year Major Adverse Cardiovascular Events After Carotid Artery Stenting: A Propensity-Matched Analysis.

📖 Top 30% JournalArticle

1 week ago • Frontiers in medicine

Using body traits and genetics to guide personalized drug treatment for obesityPhenotypic and genomic frameworks for precision pharmacotherapy in obesity: a narrative review.

📖 Top 20% JournalArticle

1 week ago • International journal of molecular sciences

Links Between GLP-1 Treatments and Gum Health: A Review of Current Findings and Future DirectionsRelationship Between GLP-1-Based Therapies and Periodontal Health: A Systematic Review of Current Evidence and Future Perspectives.

📖 Top 20% JournalSystematic Review

1 week ago • Aesthetic surgery journal. Open forum

Plastic Surgery Videos Related to GLP-1 on TikTok: A Snapshot StudyA Cross-Sectional Analysis of Plastic Surgery With GLP-1-Related Content on TikTok.

Article

1 week ago • Nutrients

Understanding Obesity as a Disease Affecting Multiple Body Systems: Improving Research, Diagnosis, and TreatmentUnderstanding Obesity as a Multisystem Disease: Advancing Research, Redefining Diagnostic Criteria, and Establishing Modern Therapeutic Approaches.

🎖️ Top 10% JournalArticle

1 week ago • HIV medicine

Semaglutide improves fatty liver and liver inflammation in people with HIVSemaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study.

Article

1 week ago • Diabetes, obesity & metabolism

Comparing the effects of low-dose tirzepatide (2.5 mg vs 5 mg) for obesity in non-diabetic Japanese adultsLow-Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non-Diabetic Japanese Adults.

Article

1 week ago • Diabetes, obesity & metabolism

GLP-1 Medicines and Skin Cancer Risk in Adults with Type 2 DiabetesGLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation.

Article

1 week ago • British journal of clinical pharmacology

How different doses of oral semaglutide affect artery stiffness and the added impact of SGLT-2 inhibitors in type 2 diabetesDose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes.

📖 Top 20% JournalArticle

1 week ago • Internal and emergency medicine

How GLP-1 receptor activators relate to diabetes, fatty liver disease, and liver cancerGLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma.

Article

1 week ago • The Journal of nutrition

Diet Quality and Vitamin and Mineral Intake in U.S. Adults Who May Qualify for Weight-Loss DrugsDiet Quality and Micronutrient Intake Among U.S. Adults Eligible for GLP-1 Receptor Agonist Anti-Obesity Medications: A Nationally Representative Analysis.

Article

1 week ago • Drug design, development and therapy

Real-world weight loss with different GLP-1 medicines in the All of Us studyReal-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study.

📖 Top 20% JournalComparative Study

1 week ago • Obesity pillars

US workers' views and experiences with tirzepatide for obesity or overweight from the PERCEPTIONS SurveyEmployee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey.

📖 Top 20% JournalArticle

1 week ago • International journal of molecular sciences

How Psyllium and Glucomannan Fibers Influence Gut Bacteria, Hormones, Inflammation, and Treatment for MetabolismPsyllium and Glucomannan as Viscous Fiber Modulators of the Gut-Microbiome-Incretin Axis: Molecular Links to Metabolic Inflammation, Barrier Function, and GLP-1 Receptor Agonist Therapy.

📖 Top 20% JournalArticle

1 week ago • Journal of the American College of Clinical Pharmacy : JACCP

Factors Influencing Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Primary CareContextual Factors Affecting SGLT2 Inhibitors and GLP-1 Receptor Agonists Prescribing in Primary Care: An Application of the Consolidated Framework for Implementation Research.

📖 Top 50% JournalArticle

1 week ago • Menopause (New York, N.Y.)

Weight loss treatments and sexual function in middle-aged women: possible role of GLP-1 medicinesWeight loss interventions and sexual function in midlife women: the emerging role of glucagon-like peptide-1 receptor agonists.

📖 Top 20% JournalArticle

1 week ago • Biomedicines

Unexpected Uses of Semaglutide and Tirzepatide in Cancer and Human ReproductionUnconventional Applications of Semaglutide and Tirzepatide: From Oncology to Human Reproduction.

📖 Top 20% JournalArticle

1 week ago • British journal of clinical pharmacology

Changes in public and private use of diabetes medicines called GLP-1 in Australia from 2020 to 2025Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.

📖 Top 20% JournalArticle

1 week ago • Obesity pillars

Improvement of pleasure loss symptoms in obese patients treated with tirzepatide: A report on three casesResolution of anhedonia-like symptoms in patients treated for obesity with tirzepatide: A three-case series.

📖 Top 20% JournalCase Reports

1 week ago • Journal of cardiovascular pharmacology

Incretin-based treatments, alcohol and tobacco use, and sudden substance-related heart problems: new insights for heart medicineIncretin-based therapies, alcohol and tobacco use, and acute substance-related events: emerging implications for cardiovascular medicine.

📖 Top 30% JournalArticle

← prevpage 4 of 14next →

Latest GLP-1 Therapies Research Papers